The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Thanks Steamy...
Lewis...I agree that you cannot compare companies. The difference here is GDR's quality of products in their range and what the potential is with each of them. Not the quantity of products. It is the potential of each to change the Companies financial structure.....
@maestro1
I have read the RNS's. You need to read this. There you will see the CE was approved last week!
https://covid-19-diagnostics.jrc.ec.europa.eu/devices/detail/2524
@Newbee007
Everyone is referring to the CE mark RNS and when we're going to get an update. It was updated last Friday.
Totally agree about sales etc, but that is a different topic.
To be fair, they have followed similar price action in the past. Probably just covid sentiment though. Not sure GDR will reach Novacyts highs.
How to spot a lowbrow, Fig. 1 : he looks at price charts and somehow concludes that two given companies are very similar, even though they operate at different scales and even though their respective price actions have sprung in very different contexts.
Ā£12 sounds good! Hope you're right anyway.
I couldnt really say Newbee007... no one really can in all honesty lol. I however do believe the positive RNS is due anytime in the next couple of days- just a bit of patience and we could all see ourselves double our shares here. GLA!!
@Steamy - Are you serious?
How about a Contract? Sales? Distribution?
Everything else is just fluff!
re latest RNS - the sentiment can be taken actually as positive, as it was already something to occur...what is good to hear though, is that it's the "final tranche" and therefore just an announcement for formality.
dilution will be negligible and so no issue
The wrong rns has come out, still the wait for the approval.
Ppl got excited too early, rinse and repeat, consolidation in the 40s now..
The problem with the RNS wording is it implies registration is a formality. It cannot be true that self certification is all that is required to validate the kit.
Steamy you need to read rns's
"Following self-certification, the GenedriveĀ® COV19-ID Kit has been passed to genedrive's Authorised Representative for formal registration, a process expected to take ten working days to complete, following which the product can be made available commercially in the European Union. In parallel, the product is being provided for review and evaluation to a range of potential commercial partners who have actively expressed interest in the product."
What are we expecting the content of the awaited RNS to contain?
We already know that the EU have given the CE status last Friday. What more is there to know?
Hi ExperTrader,
Why would they issue an after hours RNS? Because they have another one lined up for tomorrow 7am?
Here's hoping :)
Missed The last few hours of trading but seems like Genedrive held up (was no doubt tbh). Seems like RNS/News may still come out Tuesday/Wednesday as i initially predicted... huge increase already and the week has just begun lol. Roll on Tuesday :)
Also for those not knowing- this RNS after COP today means nothing, in affecting the share price in all honesty, so dont worry- 500,000k shares pffftttt :D GLA